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a b s t r a c t
Background: Home blood pressure monitoring (HBPM) is recommended for hypertensive
patients as a tool to improve both blood pressure (BP) control and compliance with treatment.
Methods: We evaluated the use of HBPM in hypertensive subjects examined during a cross-
sectional general population survey (Czech post-MONICA). Models predicting the availability
and use of HBPM were constructed using univariate and multivariate logistic regression.
Results: Of 449 treated hypertensive patients (mean age 63.2 years, 52.1% women), 250
(55.7%) reported that they had a device for BP monitoring available at home. The factors
associated with HBPM availability were older age, university education, marital status,
longer duration of hypertension and nonsmoking. Of the 250 subjects with HBPM available,
40% used HBPM regularly (at least once a week), and this ratio increased with the number of
antihypertensive drugs taken (monotherapy 30%, dual combination 43%, combination of 3
drugs 48%; ptrend = 0.028). BP control was similar in those using HBPM regularly and those
who used HBPM irregularly or did not use it at all (54.5 vs. 49.7%; p = 0.52).
Conclusion: HBPM is available to more than a half of treated hypertensive patients from the
general population. However, only minority of the patients perform home blood pressure
measurement regularly.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.




Home blood pressure monitoring (HBPM) eliminates some
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its use helps to differentiate masked, white-coat and sustained
arterial hypertension. Moreover, it correlates more closely
with target organ damage [1] and cardiovascular mortality [2]
than does ofﬁce blood pressure.f Medicine in Pilsen, Charles University, Edvarda Beneše 13, 305 99
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to the majority of patients with known or suspected hyperten-
sion [3–5]. Home blood pressure monitoring is useful for
monitoring the response to antihypertensive treatment in daily
practice [3–5] and may improve adherence to treatment [6]. It
has been shown that the use of HBPM is associated with better
blood pressure (BP) control [7]. The prevalence of HBPM use in
hypertensive patients ranges from 24% to 75% [8,9]. However,
data about the use of HBPM in Central Europe remain unknown.
The aim of the present study was therefore to investigate
the availability of HBPM in a sample from the Czech general
population. Moreover, we investigated which factors are
associated with regular HBPM use and whether regular HBPM
use is associated with better blood pressure control.
Methods
Study population
The Czech post-MONICA (MONItoring trends and determi-
nants in CArdiovascular disease) study is a population survey
studying trends and determinants of cardiovascular risk
factors in a 1% random sample of the Czech population in
nine districts of the country. Methods of the Czech post-
MONICA study are described elsewhere [10]. All participants
gave written informed consent. The study was approved by the
local ethics committee of the University Hospital in Pilsen, and
was in accordance with the Declaration of Helsinki. Our study
included subjects aged 25–75 years, permanently residing in
Pilsen district. The response rate in this district was 68%. For
the present analysis we selected 552 subjects (41.7%) who self-
reported having hypertension diagnosed by a health care
professional.
The research protocol included the administration of a
standardized questionnaire to obtain information on each
subject's medical history, HBPM and medication use. The
questionnaire was ﬁlled in and blood pressure measurement
was carried out during a single visit at clinic. Blood pressure
was measured three times in the right arm with the subject in
the sitting position after at least 5 min at rest. Standard
mercury sphygmomanometers and correctly sized cuffs were
used. The participant's right arm was supported at heart level.
The maximum inﬂation level was determined before the
actual measurement. Blood pressure values were recorded to
the nearest 2 mmHg. The mean value of the last two readings
was used for further analysis. Diabetes mellitus (DM) was
deﬁned as the use of antidiabetic treatment or fasting
glycemia 7.0 mmol/l or postprandial glycemia 11.1 mmol/
l. History of cardiovascular complication was deﬁned as
history of myocardial infarction, angina pectoris, revasculari-
zation, stroke or transient ischemic attack.
Statistical methods
For database management and statistical analyses, we used
SAS software, version 9.3 (SAS Institute Inc., Cary, NC, USA).
We compared the groups of subjects using the Fisher exact
test. We searched for factors associated with HBPM availability
and use using univariate and multivariate logistic regressionanalyses. Only covariates at least borderline signiﬁcant in
univariate models were considered to enter the multivariate
regression models. For evaluation of trend across subgroups of
patients, we used the Cochran–Armitage trend test.
Results
Characteristics of participants
Of the 552 participants who reported having arterial hyper-
tension, 263 (48%) reported that they had a device for BP
measurement available at home. In further analyses, we
focused only on 449 (81.3%) patients currently using antihy-
pertensive drugs. In these treated subjects, the availability of
HBPM was slightly higher (55%). Correlates of HBPM availabili-
ty are listed in Table 1. The availability of HBPM was equal
among men and women, diabetics and non-diabetics, and
patients with and without a history of cardiovascular
complications ( p for all 0.14). Home blood pressure monitor-
ing availability was higher among older subjects (>65 years)
than among younger subjects (< 50 years; odds ratio [OR] 2.80,
95% conﬁdence interval [95%CI] 1.38–5.69), in patients with
university education (when compared with subjects with
primary education, the unadjusted OR was equal to 1.76, 95%
CI: 1.00–3.08), married subjects (unadjusted OR 2.77, 95%CI:
1.79–4.28), and in patients with longer duration of hyperten-
sion. On the other hand, current smokers had HBPM less
available than nonsmokers (OR 0.56, 95%CI: 0.35–0.91; Table 1).
Results of multivariate regression analysis were similar to that
obtained using univariate regression models, except for
current smoking which was no longer associated with HBPM
availability (adjusted OR 0.81, 95%CI: 0.49–1.35).
Control of hypertension (BP <140/90 mmHg) did not differ
between the two groups (51.6 vs. 59.3%; p = 0.11).
Correlates of regular (at least once a week) home blood
pressure measurement
In the next step we investigated which factors were associated
with regular use of HBPM (Table 2). Forty percent of treated
hypertensive patients performed regular home BP measure-
ment and this ratio increased moderately with the number of
antihypertensive drugs used (on monotherapy 30%, on dual
combination 43%, and on combination of 3 drugs 48%; p for
trend = 0.028; Fig. 1). Another marginally signiﬁcant factor was
the presence of DM (OR 1.82, 95%CI: 0.99–3.31). We did not
observe any difference between those who regularly used
HBPM compared with those who measured their home BP
irregularly or did not measure it at all, in respect of age, sex,
education, duration of hypertension, marital status, and a
history of cardiovascular complications ( p  0.34; Table 2).
Furthermore, we constructed a multivariate logistic regression
model with the number of antihypertensive drugs and DM as
independent variables. The results of this analysis were
conﬁrmatory to univariate regression (Table 3).
Blood pressure control was similar in both the groups (54.5
vs. 49.7%; p = 0.52) as well as in subgroups of subjects treated
by monotherapy or by combination therapy ( p  0.56; data not
shown).









Female 234 128 (51.2) 106 (53.3) 1 –
Male 215 122 (48.8) 93 (46.7) 1.09 0.75–1.58
Age group, years
25–50 38 15 (6.0) 23 (11.6) 1 –
51–65 199 98 (39.2) 101 (50.7) 1.49 0.73–3.02
>65 212 137 (54.8) 75 (37.7) 2.80 1.38–5.69
Education
Primary 186 98 (39.2) 88 (44.2) 1 –
Secondary 189 103 (41.2) 86 (43.2) 1.07 0.72–1.61
University 74 49 (19.6) 25 (12.6) 1.76 1.00–3.08
Marital status
Single, divorced, widowed 118 44 (17.6) 74 (37.2) 1 –
Married, civil partnership 331 206 (82.4) 125 (62.8) 2.77 1.79–4.28
Known duration of HT, years
Up to 5 159 69 (27.6) 90 (45.2) 1 –
6–10 109 61 (24.4) 48 (24.1) 1.66 1.01–2.71
>10 181 120 (48.0) 61 (30.7) 2.57 1.65–3.98
Controlled HT
Yes (BP <140/90 mmHg) 247 129 (51.6) 118 (59.3) 1 –
No 202 121 (48.4) 81 (40.7) 1.37 0.94–1.99
Number of antihypertensive drugs
Monotherapy 161 82 (32.8) 79 (39.7) 1 –
Dual combination 173 99 (39.6) 74 (37.2) 1.29 0.84–1.98
Combination of 3 drugs 115 69 (27.6) 46 (23.1) 1.44 0.89–2.35
History of CV complications
No 358 193 (77.2) 165 (82.9) 1 –
Yes 91 57 (22.8) 34 (17.1) 1.43 0.89–2.30
Diabetes mellitus
No 337 194 (77.6) 143 (71.9) 1 –
Yes 112 56 (22.4) 56 (28.1) 0.74 0.48–1.13
Current smoking
No 363 212 (84.8) 151 (75.6) 1 –
Yes 86 38 (15.2) 48 (24.1) 0.56 0.35–0.91
HT, hypertension; CV, cardiovascular.
Fig. 1 – Frequency of HBPM performance in treated
hypertensive patients according to the number of
antihypertensive drugs taken. Number of subjects in each
group is given. Regular use of HBPM = measurement at
least once a week; p for trend was calculated using the
Cochran–Armitage trend test.
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The key ﬁnding of our study is that more than a half of treated
hypertensive patients from the Czech general population have
BP monitors available at home. However, only 40% of them
perform BP measurement regularly and this ratio moderately
increases with the number of antihypertensive drugs used. We
did not observe a difference in hypertension control (based on
mean value of the measurements taken during single visit at
the ofﬁce) between those who regularly measured their BP at
home and those who did not.
Only few papers have investigated the availability and use
of HBPM [11–15]. The ownership of HBPM among hypertensive
patients ranged between 46% in Turkey [11] and 78% in Canada
[12]. Our ﬁndings are within this range. The observed factors
associated with availability of the device are not surprising.
However, the availability of the device does not mean that it is
used. Use of HBPM is recommended for most of the
hypertensive patients [5]. The observed 40% of regular HBPM
users in our survey is relatively low. The reason for non-
adherence to HBPM might be largely personal (forgetting, not
having time, or self/described laziness) [16]. However, other









Female 128 49 (48.5) 79 (53.0) 1 –
Male 122 52 (51.5) 70 (47.0) 1.20 0.72–1.99
Age group, years
25–50 15 5 (4.9) 10 (6.7) 1 –
51–65 98 35 (34.7) 63 (42.3) 1.11 0.35–3.51
>65 137 61 (60.4) 76 (51.0) 1.60 0.52–4.94
Education
Primary 98 42 (41.6) 56 (37.6) 1 –
Secondary 103 42 (41.6) 61 (40.9) 0.92 0.52–1.61
University 49 17 (16.8) 32 (21.5) 0.71 0.35–1.44
Marital status
Single, divorced, widowed 44 16 (15.8) 28 (18.8) 1 –
Married, civil partnership 206 85 (84.2) 121 (81.2) 1.23 0.63–2.41
Known duration of HT, years
Up to 5 69 27 (26.7) 42 (28.2) 1 –
6–10 61 24 (23.8) 37 (24.8) 1.01 0.50–2.04
>10 120 50 (49.5) 70 (47.0) 1.11 0.61–2.03
Controlled HT
Yes (BP <140/90 mmHg) 129 55 (54.5) 74 (49.7) 1 –
No 121 46 (45.5) 75 (50.3) 0.82 0.50–1.37
Number of antihypertensive drugs
Monotherapy 82 25 (24.7) 57 (38.3) 1 –
Dual combination 99 43 (42.6) 56 (37.5) 1.75 0.95–3.24
Combination of 3 drugs 69 33 (32.7) 36 (24.2) 2.09 1.07–4.07
History of CV complications
No 193 75 (74.3) 118 (79.2) 1 –
Yes 57 26 (25.7) 31 (20.8) 1.32 0.73–2.39
Diabetes mellitus
No 194 72 (71.3) 122 (81.9) 1 –
Yes 56 29 (28.7) 27 (18.1) 1.82 0.99–3.31
Current smoking
No 212 87 (86.1) 125 (83.9) 1 –
Yes 38 14 (13.9) 24 (16.1) 0.84 0.41–1.71
For explanation, see Table 1.
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values and lack of knowledge of HBPM both in patients and
their physicians might be also contributing factors [16]. In view
of the fact that HBPM might improve adherence to treatment
[6], which is low in arterial hypertension [17,18], more
emphasis on implementing HBPM as a daily clinical practice
is needed.
Regular HBPM use differs across patient populations. In
studies involving primary care patients, regular use of HBPM
was approximately 40% [13/15]. In treated hypertensiveTable 3 – Factors associated with the use of HBPM in
treated patients using multivariate analysis.
OR 95%CI
Number of antihypertensive drugs
Monotherapy 1 –
Dual combination 1.74 0.94–3.23




OR, odds ratio; CI, conﬁdence interval.patients selected from a general population we observed a
similar number. In patients attending the specialized hyper-
tension clinics, the ratio of regular users is substantially higher
(66–75%) [8,19]. Therefore, the activity oriented on spreading of
knowledge about HBPM beneﬁts should be aimed predomi-
nantly at general practitioners.
To the best of our knowledge, no previous study has
investigated whether regular practicing of HBPM relates to the
number of antihypertensive drugs used and thus approxi-
mately to the severity of hypertension. Our ﬁnding that regular
use of HBPM correlates with the number of medications used
might imply that subjects with a more severe hypertension
tend to control their BP more. One can presume that also
subjects at high cardiovascular risk will be more cautious
about their risk factors and adhere more to HBPM. However, we
did not observe a trend for more frequent HBPM use in these
subjects. Cuspidi et al. [19] reported that hypertensive patients
using HBPM had better control of hypertension compared with
HBPM nonusers (49.2 vs. 45.6%). In our case, the difference in
hypertension control (based on mean value of occasional ofﬁce
BP values) between the two groups of patients was similar to
that of the above-mentioned study (54.5 vs. 49.7%); however,
probably due to the smaller sample size, the observed
difference was not statistically signiﬁcant.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 1 5 8 – e 1 6 3e162The limitations of this study should be mentioned. First, BP
values and hypertension control were based on occasional
ofﬁce BP levels measured at rest and not conﬁrmed by 24-h
ambulatory BP measurement or confronted with HBPM values.
Second, we did not investigate the type of devices used by
patients and their reliability.
Conclusions
In conclusion, our cross-sectional observational survey indi-
cates that devices for BP measurement are available to more
than a half of treated hypertensive patients of the Czech
general population. Home blood pressure monitoring is
regularly performed by only 40% of patients who own a home
BP monitor, while the ratio of users tends to increase with the
number of antihypertensive medication used. Therefore, more
emphasis must be placed on implementing home blood
pressure measurement in daily clinical practice.
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